Our latest thinking, insights and company news

Never miss an update, subscribe today.

RJW&partners will only use your personal information to administer your account and provide the products and services you request. You can unsubscribe at any time, to do so please review our Privacy Policy. By clicking subscribe, you consent to allow RJW&partners to store and process your personal information.

Apr 14, 2022
9 min

Will US payers cope with the influx of high-cost cell and gene therapies over the coming years?

A summary of some of the challenges and solutions associated with cell and gene therapy coverage and pricing in the US

300 views

Mar 23, 2022
2 min

Is it business as usual for Pharma in Russia?

A summary of the impact of Russia invasion of Ukraine on the biopharmaceutical industry so far

129 views

Mar 22, 2022
14 min

Rare diseases are not that rare after all...

What are the key drivers of willingness to pay for Orphan Medical Products (OMPs) in the UK, France, Germany, Italy & Spain?

53 views

Dec 17, 2021
10 min

What have NICE and NHS England been up to in 2021?

A summary of some of the key changes and announcements made by NICE and NHS England and NHS Improvement during 2021

157 views

Sep 7, 2021
5 min

How copay accumulators and maximizers are shifting drug costs to patients and manufacturers

Recently, healthcare insurance companies and PBMs have been leveraging two new strategies that shift further costs onto commercially-covered

3,939 views

Jun 29, 2021
4 min

The management of orphan drug prices after loss of exclusivity

What happens to orphan drugs when they lose market exclusivity? Do they face generic competition and price reductions like other drugs?...

762 views

Jun 9, 2021
4 min

Biden and big change: is he just getting started?

Biden has unveiled his proposed 2022 budget, which reveals his healthcare policy priorities but lacks financial details.

46 views

Jun 3, 2021
5 min

Biosimilar uptake: will the US catch up with Europe?

Uptake of biosimilars has been much slower in the US compared to Europe. Could recent and upcoming reforms change this?

90 views

Mar 31, 2021
4 min

Back to the future: Covid-19 has increased the appetite for centralisation of decision-making

NHS England is set to achieve its commitment to roll out Integrated Care System (ICSs) across England by April 2022.

140 views

Mar 22, 2021
3 min

Germany mandates real-world data collection for gene therapy Zolgensma

Germany’s HTA body is telling Novartis exactly what post-approval efficacy data it needs to see for SMA therapy Zolgensma.

803 views

Our latest thinking, insights and company news

Never miss an update, subscribe today.

​